Marked induction of matrix metalloproteinase-10 by respiratory syncytial virus infection in human nasal epithelial cells

Journal of Medical Virology

Volumn 85, Issue 12, 2013, Pages 2141-2150

  Hirakawa, Satoshi ^a   Kojima, Takashi ^a   Obata, Kazufumi ^a   Okabayashi, Tamaki ^b   Yokota, Shin ichi ^a   Nomura, Kazuaki ^a   Obonai, Toshimasa ^c   Fuchimoto, Jun ^a   Himi, Tetsuo ^a   Tsutsumi, Hiroyuki ^a   Sawada, Norimasa ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c Tokyo Metropolitan Health and Medical Treatment Corporation   (Japan)

Author keywords

Human nasal epithelial cells; MMP 10; RSV; Signal transduction; Tight junctions

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GELATINASE B; I KAPPA B; INTERSTITIAL COLLAGENASE; MACROPHAGE ELASTASE; MATRILYSIN; MATRIX METALLOPROTEINASE 15; MATRIX METALLOPROTEINASE 19; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C INHIBITOR; RANTES; STROMELYSIN 2; TIGHT JUNCTION PROTEIN;

ARTICLE; BRONCHUS MUCOSA; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG ALVEOLUS EPITHELIUM; MACROPHAGE; NUCLEOTIDE SEQUENCE; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY SYNCYTIAL VIRUS INFECTION; SIGNAL TRANSDUCTION; UPREGULATION; VIRUS REPLICATION;

RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

HUMAN NASAL EPITHELIAL CELLS; MMP-10; RSV; SIGNAL TRANSDUCTION; TIGHT JUNCTIONS;

CHILD; EPIDERMAL GROWTH FACTOR; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; INFANT; INFANT, NEWBORN; JANUS KINASES; LUNG; MATRIX METALLOPROTEINASE 10; MATRIX METALLOPROTEINASES; MITOGEN-ACTIVATED PROTEIN KINASES; NASAL MUCOSA; NF-KAPPA B; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS; TIGHT JUNCTIONS; VIRUS REPLICATION;

EID: 84884988197     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23718     Document Type: Article

References (27)

1. Bitko V, Barik S. 1998. Persistent activation of RelA by respiratory syncytial virus involves protein kinase C, underphosphorylated IkBb, and sequestration of protein phosphatase 2A by the viral phosphoprotein. J Virol 72:5610-5618.
2. Bitko V, Velazquez A, Yang L, Yang YC, Barik S. 1997. Transcriptional induction of multiple cytokines by human respiratory syncytial virus requires activation of NF-kappa B and is inhibited by sodium salicylate and aspirin. Virology 232:369-378.
3. Bitko V, Shulyayeva O, Mazumder B, Musiyenko A, Ramaswamy M, Look DC, Barik S. 2007. Nonstructural proteins of respiratory Syncytial virus suppress premature apoptosis by an NF-κB-dependent, interferon-independent mechanism and facilitate virus growth. J Virol 81:1786-1795.
4. Chakraborti S, Mandal M, Das S, Mandal A, Chakraborti T. 2003. Regulation of matrix metalloproteinase: An overview. Mol Cell Biochem 253:269-285.
5. Chen W, Monick MM, Carter AB, Hunninghake GW. 2000. Activation of ERK2 by respiratory syncytial virus in A549 cells is linked to the production of interleukin 8. Exp Lung Res 26:13-26.
6. Gibbs JD, Ornoff DM, Igo HA, Zeng JY, Imani F. 2009. Cell cycle arrest by transforming growth factor beta1 enhances replication of respiratory syncytial virus in lung epithelial cells. J Virol 83:12424-12431.
7. González-Mariscal L, Tapia R, Chamorro D. 2008. Crosstalk of tight junction components with signaling pathways. Biochim Biophys Acta 1778:729-756.
8. Greenlee KJ, Werb Z, Kheradmand F. 2007. Matrix metalloproteinases in lung: Multiple, multifarious, and multifaceted. Physiol Rev 87:69-98.
9. Holt PG, Strickland DH, Wikström ME, Jahnsen FL. 2008. Regulation of immunological homeostasis in the respiratory tract. Nat Rev Immunol 8:142-152.
10. Koizumi J, Kojima T, Ogasawara N, Kamekura R, Kurose M, Go M, Harimaya A, Murata M, Osanai M, Chiba H, Himi T, Sawada N. 2008. Protein kinase C enhances tight junction barrier function of human nasal epithelial cells in primary culture by transcriptional regulation. Mol Pharmacol 74:432-442.
11. Kojima T, Murata M, Yamamono T, Lan M, Imamura M, Son S, Takano K, Yamaguchi H, Ito T, Tanaka S, Chiba H, Hirata K, Sawada N. 2009. Tight junction proteins and signal transduction pathways in hepatocytes. Histol Histopathol 24:1463-1472.
12. Kong X, Juan HS, Kumar M, Behera AK, Mohapatra A, Hellermann GR, Mane S, Lockey RF, Mohapatra SS. 2003. Respiratory Syncytial virus infection activates STAT signaling in human epithelial cells. Biochem Biophys Res Commun 306:616-622.
13. Kong MYF, Gaggar A, Li Y, Winkles M, Blalock JE, Clancy JP. 2009. Matrix metalloproteinase activity in pediatric acute lung injury. Int J Med Sci 6:9-17.
14. Kurose M, Kojima T, Koizumi JI, Kamekura R, Ninomiya T, Murata M, Ichimiya S, Osanai M, Chiba H, Himi T, Sawada N. 2007. Induction of claudins in passaged hTERT-transfected human nasal epithelial cells with an extended life span. Cell Tissue Res 330:63-74.
15. Masaki T, Kojima T, Okabayashi T, Ogasawara N, Ohkuni T, Obata K, Takasawa A, Murata M, Tanaka S, Hirakawa S, Fuchimoto J, Ninomiya T, Fujii N, Tsutsumi H, Himi T, Sawada N. 2011. A nuclear factor-κB signaling pathway via protein kinase C δ regulates replication of respiratory syncytial virus in polarized normal human nasal epithelial cells. Mol Biol Cell 22:2144-2156.
16. Monick MM, Cameron K, Staber J, Powers LS, Yarovinsky TO, Koland JG, Hunninghake GW. 2005. Activation of the epidermal growth factoe receptor by respiratory Syncytial virus results in increased inflammation and delayed apoptosis. J Biol Chem 280:2147-2158.
17. Okabayashi T, Kojima T, Masaki T, Yokota S, Imaizumi T, Tsutsumi H, Himi T, Fujii N, Sawada N. 2011. Type-III interferon, not type-I, is the predominant interferon induced by respiratory viruses in nasal epithelial cells. Virus Res 160:360-366.
18. Parks WC, Wilson CL, López-Boado YS. 2004. Matrix metaloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol 4:617-629.
19. Rosenberg HF, Domachowske JB. 2012. Inflammatory responses to Respiratory syncytial virus (RSV) infection and the development of immunomodulatory pharmacotherapeutics. Curr Med Chem 19:1424-1431.
20. Schneeberger EE, Lynch RD. 1992. Structure, function, and regulation of cellular tight junctions. Am J Physiol 262:L647-L661.
21. Schuurhof A, Bont L, Hodemaekers HM, Klerk A, Groot H, Hofland RW, van de Pol AC, Kimpen JLL. 2012. Proteins involved in extracellular matrix dynamics are associated with respiratory syncytial virus disease severity. Eur Respir J 39:1475-1481.
22. Sigurs N, Aljassim F, Kjellman B, Robinson PD, Sigurbergsson F, Bjarnason R, Gustafsson PM. 2010. Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life. Thorax 65:1045-1052.
23. Tacon CE, Wiehler S, Holden NS, Newton R, Proud D, Leigh R. 2010. Human rhinovirus infection up-regulates MMP-9 production in airway epithelial cells via NF-κB. Am J Respir Cell Mol Biol 43:201-209.
24. Thomas LH, Friedland JS, Sharland M, Becker S. 1998. Respiratory syncytial virus-induced RANTES production from human bronchial epithelial cells is dependent on nuclear factor-kappa B nuclear binding and is inhibited by adenovirus-mediated expression of inhibitor of kappa B alpha. J Immunol 161:1007-1016.
25. Tregoning JS, Pribul PK, Pennycook AM, Hussell T, Wang B, Lukacs N, Schwarze J, Culley FJ, Openshaw PJ. 2010. The chemokine MIP1alpha/CCL3 determines pathology in primary RSV infection by regulating the balance of T cell populations in the murine lung. PLoS ONE 5:e9381.
26. Yeo NK, Jang YJ. 2010. Rhinovirus infection-induced alteration of tight junction and adherens junction components in human nasal epithelial cells. Laryngoscope 120:346-352.
27. Yeo SJ, Yun YJ, Lyu MA, Woo SY, Kim SJ, Lee HJ, Park HK, Kook YH. 2002. Respiratory Syncytial virus infection induces matrix metalloproteinase-9 expression in epithelial cells. Arch Virol 147:229-242.